# Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

> **NCT01358695** · PHASE2 · COMPLETED · sponsor: **Anterios Inc.** · enrollment: 111 (actual)

## Conditions studied

- Lateral Canthal Lines
- Crow's Feet

## Interventions

- **BIOLOGICAL:** ANT-1207
- **BIOLOGICAL:** Botulinum Toxin, Type A
- **BIOLOGICAL:** Botulinum Toxin Type A

## Key facts

- **NCT ID:** NCT01358695
- **Lead sponsor:** Anterios Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-02
- **Final completion:** 2012-05
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2013-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01358695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01358695, "Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01358695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*